Prenetics' IM8 Partners with Superpower to Personalize the Future of Supplementation

Rhea-AI Summary

Prenetics (NASDAQ: PRE) announced a strategic partnership between its IM8 brand and Superpower on March 24, 2026 to integrate clinical-grade supplementation with comprehensive blood diagnostics.

The deal offers IM8 90-day subscribers a $49 Superpower membership (75% off the $199 price), monthly subscribers a $99 rate, access to 100+ biomarker testing, Quest availability at >2,000 locations, and IM8 products featured in Superpower's personalized protocols.

Positive

• Superpower membership for IM8 90-day subscribers at $49 (75% saving)
• Comprehensive 100+ biomarker testing integrated with IM8 supplementation
• Testing available at over 2,000 Quest Diagnostics locations
• IM8 products featured in Superpower's personalized supplement marketplace
• IM8 ships to 31 countries, expanding partnership reach

Negative

• None.

News Market Reaction – PRE

+3.22%

8 alerts

+3.22% Session close to close

+5.9% Peak Tracked

-5.9% Trough Tracked

$397.66M Market Cap

1.2x Rel. Volume

In the Mar 24 session, PRE gained 3.22%, reflecting a moderate positive market reaction. Argus tracked a peak move of +5.9% during that session. Argus tracked a trough of -5.9% from its starting point during tracking. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement links IM8’s clinical-grade supplementation with Superpower’s 100+ biomarker testin...

Analysis

This announcement links IM8’s clinical-grade supplementation with Superpower’s 100+ biomarker testing, creating a closed-loop system that offers discounted memberships at $49 or $99 per year versus a $199 standard price. It extends Prenetics’ history of partnerships around IM8 and personalized health. Investors may watch for adoption metrics, the impact on IM8 subscriber growth, and any future updates on how biomarker outcomes validate supplement efficacy over successive 90-day cycles.

Key Figures

Superpower price (IM8 90-day): $49 per year Standard Superpower price: $199 per year Savings (90-day tier): 75% saving +5 more

8 metrics

Superpower price (IM8 90-day) $49 per year Superpower membership for IM8 90-Day Subscribers

Standard Superpower price $199 per year Standard annual Superpower membership price

Savings (90-day tier) 75% saving Discount vs standard Superpower annual price

Superpower funding over $40 million Venture funding backing Superpower

Biomarkers tested 100+ biomarkers Superpower comprehensive blood testing panel

Superpower price (monthly IM8) $99 per year Superpower membership for monthly IM8 subscribers

Savings (monthly tier) 50% saving Discount vs standard Superpower annual price

Quest locations over 2,000 locations Quest Diagnostics sites offering Superpower testing

Previous Partnership Reports

2 past events · Latest: Feb 11 (Positive)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 11	Strategic partnership	Positive	-2.1%	Genomics-based partnership with Humanity Protocol and crypto strategic reserve launch.
Jul 11	Brand partnership	Positive	+12.7%	Strategic partnership with David Beckham and co-founding of IM8 brand.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Partnership headlines have produced mixed reactions, with one positive and one negative next-day move.

Recent Company History

This announcement continues Prenetics’ use of partnerships to extend its consumer health platform. Earlier, a Feb 11, 2025 partnership with Humanity Protocol around genomics-based identity and a crypto reserve saw PRE move -2.12%, while the Jul 11, 2024 partnership with David Beckham around IM8 drove a 12.67% gain. The new Superpower tie-up again leverages IM8, this time linking clinical-grade supplementation with 100+ biomarker testing, building on the brand- and tech-focused alliances seen in prior deals.

Key Terms

biomarker, clinical-grade, AI health layer, concierge care team, +1 more

5 terms

biomarker medical

"test 100+ biomarkers, take our products for 90 days, retest"

A biomarker is a measurable indicator found in the body, such as in blood or tissues, that provides information about health, disease, or how the body responds to treatment. For investors, biomarkers can signal the potential success or risk of medical products or therapies, influencing the value of related companies and industry trends. They act like signals or clues that help assess the progress of medical advancements and their market impact.

clinical-grade medical

"connects clinical-grade supplementation with comprehensive blood diagnostics"

Clinical-grade describes products, materials, or processes manufactured and documented to meet the safety, purity and quality standards required for use in human clinical trials or medical treatments. For investors it signals higher regulatory scrutiny, bigger development and manufacturing costs, and a clearer path (or barrier) to market — like a car built to highway safety rules rather than a prototype, which affects timelines, budgets and commercial risk.

AI health layer technical

"an AI health layer grounded in each individual's real data"

An AI health layer is a software bridge that sits between raw medical data (from devices, electronic records, labs) and the apps or clinicians that use it, applying artificial intelligence to clean, combine and turn data into practical insights. For investors, it matters because this layer can speed product development, improve clinical decisions and create recurring revenue by enabling multiple services to use the same smart data foundation, similar to how a universal charger makes many devices work together more easily.

concierge care team medical

"24/7 access to its concierge care team"

A concierge care team is a small, dedicated group of healthcare professionals who coordinate and deliver highly personalized medical services, often offering faster access, extended time with patients, and proactive health management. For investors, concierge models matter because they tend to create steady, often subscription-based revenue, higher per-patient margins, and stronger patient loyalty—similar to how a premium service plan can lock in repeat customers and predictable income.

preventive health medical

"Superpower, the preventive health platform backed by over $40 million"

Preventive health consists of actions and services—like screenings, vaccinations, lifestyle programs, and early checkups—designed to stop illness or catch problems early before they become serious. For investors, preventive health matters because it can lower long-term costs, reduce hospital visits, and create steady demand for products and services; think of it as routine maintenance for a car that helps avoid expensive breakdowns later, stabilizing returns and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

• IM8 90-Day Subscribers Unlock SuperPower Blood Testing for $49 — A 75% Saving on the Standard $199 Price.
• IM8 and Superpower create the first closed-loop system in consumer health – connecting clinical-grade supplementation with 100+ biomarker blood testing.
• IM8's Daily Ultimate Essentials will be available in the Superpower supplement marketplace and featured, where biomarker data supports it, as one of Superpower's recommended foundational daily supplements in members' personalized health protocols.
  
  

NEW YORK, March 24, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced a strategic partnership with Superpower, the preventive health platform backed by over $40 million in venture funding. The first-of-its-kind partnership connects clinical-grade supplementation with comprehensive blood diagnostics, enabling an optimized testing loop to provide consumers with measurable proof behind supplement efficacy.

IM8 and Superpower are teaming up to address a fundamental gap within the wellness industry: most people who take supplements have no way to measure whether they're working; meanwhile, most blood testing platforms surface hundreds of data points, but leave consumers to navigate a fragmented, low-quality supplement market on their own. Neither side has been able to close the gap alone – until now.

Under the partnership, IM8 — co-founded by David Beckham — will integrate Superpower's annual blood testing membership into the IM8 customer journey at exclusive pricing, while Superpower will integrate IM8's Daily Ultimate Essentials into its personalized health protocols as a featured foundational nutritional ritual, available to all members on its supplement marketplace at a preferred rate. The partnership reflects a broader shift in how consumers approach their health; from reactive treatment to proactive optimization, powered by personal data.

"I co-founded IM8 with David Beckham to fix the quality problem in supplements — clinical-grade formulations, full transparency, no shortcuts," said Danny Yeung, CEO of Prenetics and IM8. "But formulation was only half the equation. The other half was measurement. With Superpower, an IM8 customer can now test 100+ biomarkers, take our products for 90 days, retest, and see measurable results. That's not a marketing claim. That's proof. No other supplement brand on the market can offer that."

[1] IM8 subscribers on the 90-day Daily Ultimate Essentials plan will be able to redeem a Superpower membership for $49 per year, which translates to a 75% saving on Superpower's standard $199 annual price. Monthly IM8 subscribers will gain access to the Superpower membership for $99 per year, a 50% saving. Both tiers include Superpower's complete offering: its comprehensive initial 100+ biomarker test, an AI health layer grounded in each individual's real data – not generic advice, and 24/7 access to its concierge care team. Members can upload past labs, share their health history, and get personalized insights to help them achieve their health goals. Testing is available at over 2,000 Quest Diagnostics locations nationwide, or via at-home blood draw for an additional fee. Baseline biomarker retests and additional specialty diagnostic tests are also available to members at preferred pricing.

[2] "We built Superpower to move healthcare from reactive to proactive – but proactive only works when testing leads to action, and action leads back to testing," said Max Marchione, Co-Founder and CEO of Superpower. "That feedback loop has never existed in consumer health until now. IM8 gives our members a supplement protocol we can stand behind with full confidence — clinical-grade formulations built for the same standard of evidence our platform is built on. This is what the future of health looks like: data in, protocol out, results measured."

IM8 ships to 31 countries and counts tennis world number one Aryna Sabalenka and Formula 1 driver Ollie Bearman among its brand ambassadors. Superpower's investors include NBA champion Giannis Antetokounmpo and the Winklevoss twins, and the platform has built the infrastructure to make preventive blood testing as routine and affordable as a gym membership.

The integrated offering is available now. To learn more, IM8 customers can access Superpower membership pricing at im8health.com, and Superpower members can explore IM8's product range at superpower.com.

About Prenetics

Prenetics (NASDAQ: PRE) is a leading health sciences company dedicated to advancing human health and longevity. The Company's flagship consumer brand, IM8, co-founded with David Beckham and championed by World No. 1 tennis player Aryna Sabalenka, is redefining the premium daily nutrition category through science-backed formulations and global brand partnerships. Since its launch, IM8 has become one of the fastest-growing brands in consumer health, achieving an impressive milestone of surpassing $100 million in annualized recurring revenue within just 11 months of operations, and is now sold in more than 31 countries worldwide.

About IM8

IM8 is the pinnacle of premium core nutrition, born from a collaboration between David Beckham as a co-founding partner, and an elite team of scientists spanning medical professionals, academia and space science. Combining cutting-edge science with nature's most potent ingredients, IM8 delivers a holistic, science-backed approach to health, empowering you to live your most vibrant life. IM8's flagship product, Daily Ultimate Essentials is an all-in-one powder supplement engineered to replace 16 different supplements in a delicious drink and is NSF Certified for Sport, non-GMO, vegan, free from common allergens, and contains no artificial flavors, colors or sweeteners. IM8 is a subsidiary of Prenetics (NASDAQ: PRE), a leading global health sciences company dedicated to advancing consumer health. To learn more about IM8, please visit www.IM8health.com.

About Superpower

Superpower is a new kind of health membership - built on comprehensive lab work, not guesswork. For $199 per year, members get annual blood testing across 100+ biomarkers, an AI health layer grounded in their real data, personalized health protocols, and 24/7 concierge care. Founded by Max Marchione and Jacob Peters, Superpower has raised over $40 million in funding with its Series A led by Forerunner Ventures. Superpower is accessible at over 2,000 Quest Diagnostics locations across the US, with at-home blood draws also available. To learn more about Superpower, please visit superpower.com.

Investor Relations Contact:
investors@prenetics.com
PRE@mzgroup.us

Angela Cheung
Investor Relations / Corporate Finance
angela.hm.cheung@prenetics.com

FAQ

What does Prenetics (PRE) announce about IM8 and Superpower on March 24, 2026?

They announced a strategic partnership to link IM8 supplementation with Superpower blood testing and personalization. According to the company, the integration offers 100+ biomarker testing, personalized protocols, and marketplace placement for IM8 products.

How much does the Superpower membership cost for IM8 90-day subscribers (PRE) after the March 24, 2026 deal?

IM8 90-day subscribers can redeem Superpower membership for $49, a 75% saving versus the standard $199. According to the company, the offer includes the initial 100+ biomarker test and AI-driven personalized insights.

What testing access does the IM8–Superpower partnership provide to PRE customers?

Customers gain access to Superpower's initial 100+ biomarker blood test and retesting at preferred pricing. According to the company, testing is available at over 2,000 Quest locations or via at-home draw for an extra fee.

Will IM8 products be integrated into Superpower's personalization for PRE members?

Yes. IM8's Daily Ultimate Essentials will appear as a featured foundational supplement in Superpower protocols where biomarker data supports it. According to the company, products will be available in Superpower's supplement marketplace at preferred rates.

Where can investors and customers find the IM8–Superpower offering details for PRE after March 24, 2026?

The integrated offering is available now and pricing details are on IM8 and Superpower websites. According to the company, IM8 customers access Superpower pricing at im8health.com and Superpower members can view IM8 at superpower.com.